FDA Approves Monoferric (ferric derisomaltose) Injection for the Treatment of Iron Deficiency Anemia

FDA Approves Monoferric (ferric derisomaltose) Injection for the Treatment of Iron Deficiency Anemia Print this page MORRISTOWN, N.J., Jan. 29, 2020 /PRNewswire/ — Pharmacosmos Therapeutics Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Monoferric® (ferric derisomaltose) injection 100 mg/mL.  Monoferric® is an intravenous iron indicated for the treatment of iron… Read More »

Payers, employers protest price transparency rule as wrong-headed

Dive Brief: The nation’s health insurance lobby pushed back against the Trump administration’s attempt to wrangle insurers into a broader effort to force the secret, negotiated rates with hospitals out into the open, according to comments submitted to the federal government on the proposed rule.  Employer groups also expressed skepticism, worried the disclosure will clash… Read More »